Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Clinical Study to Evaluate the Safety and Efficacy of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

NCT05234580 is registered in ClinicalTrials.gov with Anhui Palo Alto Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05234580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05234580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Clinical Study to Evaluate the Safety and Efficacy of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
Lead sponsor
Anhui Palo Alto Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 15, 2022
Completion date
December 25, 2022
Enrollment
204 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis